Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntegraFin Holdings Regulatory News (IHP)

Share Price Information for IntegraFin Holdings (IHP)

Share Price is delayed by 15 minutes
Get Live Data
362.50    3.50 (0.97%)
Bid:
362.50
Ask:
363.50
Spread: 1.00 (0.276%)
Market Cap: £1.20b
IHP Live PriceLast checked at - London Stock Exchange

Intraday IntegraFin Holdings Share Chart

Trading Statement

10 Nov 2022 07:00

RNS Number : 9086F
IntegraFin Holdings plc
10 November 2022
Β 

IntegraFin Holdings plc

IHP Group Trading Update ahead of full year 2022 results

For Immediate Release

10 November 2022

IntegraFin Holdings plc (''IHP'') today issues a Trading Update in respect of the financial year ended 30 September 2022. Overall, the Group is performing well, and we expect to report adjusted profit before tax for the full year which is moderately above the top end of the range of current analyst consensus estimates.

The uplift to our guidance reflects the Group's latest accounting updates including life insurance company calculations, provision releases, and other assessments. IHP is therefore now able to provide the following guidance on its results for the financial year ended 30 September 2022:

Β 

Β· Total Group revenue is expected to be Β£133.5m

Β 

Β· Net interest income is expected to be Β£0.6m as a result of interest rate tailwinds

Β 

Β· Tax recoveries relating to life insurance are expected to result in other income that is Β£0.2m higher than in the prior year

Β 

Β· Tax recoveries relating to research and development are expected to result in a credit to other costs of Β£0.3m

Β 

Β· Occupancy costs are expected to be Β£0.3m lower than the guidance we provided in July 2022, due to a one-off release of a dilapidation provision

Β 

Β· Staff costs are expected to be Β£0.7m lower than the guidance we provided in July 2022, due to the now agreed release of specific costs for the year ending 30 September 2022

Β 

The cost guidance for the financial years ending 30 September 2023, and 30 September 2024, remains unchanged.

We look forward to providing our year end results on 14 December 2022.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 (WHICH FORMS PART OF DOMESTIC UK LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("EUWA")) ("UK MAR")

LEI Number:Β 213800CYIZKXK9PQYE87Β 

Β 

Enquiries

Luke Carrivick - IHP Head of Investor Relations +44 (0)20 7608 5463

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTDGBDBUXGDGDC
Date   Source Headline
9th Mar 20217:00 amRNSResult of AGM
23rd Feb 20212:21 pmRNSDirector/PDMR Shareholding
18th Feb 20214:19 pmRNSHolding(s) in Company
10th Feb 20214:30 pmRNSHolding(s) in Company
4th Feb 20212:28 pmRNSDirector/PDMR Shareholding
27th Jan 20211:51 pmRNSDirector/PDMR Shareholding
22nd Jan 20213:28 pmRNSDirector/PDMR Shareholding
20th Jan 20212:00 pmRNSNotice of AGM
19th Jan 20217:00 amRNS1st Quarter Results
15th Jan 20211:47 pmRNSDirector/PDMR Shareholding
13th Jan 20214:08 pmRNSHolding(s) in Company
11th Jan 20212:34 pmRNSHolding(s) in Company
11th Jan 202111:30 amRNSAcquisition
5th Jan 20216:28 pmRNSListing Rule 9.6.14(R) Disclosure
4th Jan 20214:45 pmRNSNo intention to make an offer for Nucleus
23rd Dec 20201:42 pmRNSDirector/PDMR Shareholding
17th Dec 202010:00 amRNSHolding(s) in Company
17th Dec 20207:00 amRNSFinal Results
2nd Dec 20205:35 pmRNSStatement re Nucleus Financial Group plc
25th Nov 20207:00 amRNSAppointment of Joint Corporate Broker
24th Nov 20204:48 pmRNSDirector/PDMR Shareholding
5th Nov 202011:37 amRNSHolding(s) in Company
23rd Oct 20203:29 pmRNSDirector/PDMR Shareholding
20th Oct 20207:00 amRNSQ4 Funds Under Direction Update
30th Sep 202011:04 amRNSResult of General Meeting
28th Sep 20204:21 pmRNSHolding(s) in Company
25th Sep 202010:52 amRNSHolding(s) in Company
23rd Sep 20204:54 pmRNSHolding(s) in Company
23rd Sep 20204:22 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
15th Sep 20203:35 pmRNSDirector/PDMR Shareholding
9th Sep 20207:00 amRNSNotice of GM
7th Sep 202012:30 pmRNSDirector/PDMR Shareholding
1st Sep 20201:00 pmRNSDirectorate Change
24th Aug 20203:13 pmRNSDirector/PDMR Shareholding
5th Aug 20204:54 pmRNSDirector/PDMR Shareholding
4th Aug 20201:43 pmRNSHolding(s) in Company
3rd Aug 20209:45 amRNSHolding(s) in Company
27th Jul 202011:40 amRNSDirector/PDMR Shareholding
24th Jul 20203:16 pmRNSHolding(s) in Company
22nd Jul 20202:01 pmRNSDirector/PDMR Shareholding
22nd Jul 202012:00 pmRNSHolding(s) in Company
21st Jul 20207:00 amRNSQ3 Funds Under Direction Update
14th Jul 20202:30 pmRNSHolding(s) in Company
29th Jun 20203:10 pmRNSDirector/PDMR Shareholding
25th Jun 202010:27 amRNSDirector/PDMR Shareholding
24th Jun 202010:21 amRNSDirector/PDMR Shareholding
1st Jun 20201:35 pmRNSDirector/PDMR Shareholding
22nd May 20204:11 pmRNSHolding(s) in Company
22nd May 20202:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.